SEC Form 4 · accession 0001209191-16-124855
FIVE PRIME THERAPEUTICS INC · FPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Steven Sikorski
Officer — SVP and Chief Medical Officer
Period of report
Jun 1, 2016
Accepted (ET)
Jun 1, 2016 · 7:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175505
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jun 1, 2016 | A | 10,000 | $0.00 | A | 112,156 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F3 | $45.24 | Jun 1, 2016 | A | 35,000 | A | — | May 31, 2026 | Common Stock | 35,000 | 35,000 | D |
Explanation of responses
- F1Represents shares of restricted common stock, which will vest according to the following schedule: one-third (1/3) of the restricted stock will vest on each anniversary of June 1, 2016, provided the reporting person remains employed by the Issuer through each such date.
- F2Includes 732 shares acquired on May 15, 2016 pursuant to the Issuer's 2013 Employee Stock Purchase Plan.
- F3The shares underlying the option vest at a rate of one forty-eighth (1/48th) per month, provided the reporting person remains employed by the Issuer through each such date.